Chronic insulin infusion for up to 28 days did not significantly increase mean arterial pressure or potentiate angiotensin II-induced hypertension in dogs.
Hypertension
Insulin infusion (0.5 or 1.0 mU/kg/min, IV)
Sustained increases in mean arterial pressure (MAP)
The aim of this study was to determine whether chronic hyperinsulinemia, comparable to that found in obesity-associated hypertension, causes sustained increases in mean arterial pressure (MAP) or potentiates the hypertensive effects of angiotensin II (ANG II). Insulin infusion (0.5 or 1.0 mU/kg/min, IV), with plasma glucose held constant by IV glucose infusion, for seven to 28 days raised plasma insulin by five- to ten-fold, but did not significantly change MAP in dogs with reduced kidney mass that were maintained on high sodium intake. In dogs infused with ANG II to cause mild hypertension, insulin for 28 days did not potentiate the hypertension. Insulin infusion did, however, cause modest sodium retention during the first few days of infusion. These findings suggest that additional factors besides hyperinsulinemia per se are responsible for obesity-associated hypertension.
Building similarity graph...
Analyzing shared references across papers
Loading...
John E. Hall
Canadian Institute for Advanced Research
Thomas G. Coleman
University of Mississippi Medical Center
H. L. Mizelle
Orlando Regional Medical Center
American Journal of Hypertension
University of Mississippi Medical Center
Jackson Memorial Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Hall et al. (Wed,) conducted a other in Hypertension. Insulin infusion was evaluated on Sustained increases in mean arterial pressure (MAP). Chronic insulin infusion for up to 28 days did not significantly increase mean arterial pressure or potentiate angiotensin II-induced hypertension in dogs.
synapsesocial.com/papers/6a0808cd1e8b9db648ddeaff — DOI: https://doi.org/10.1093/ajh/2.3.171